Can Allegra (fexofenadine) cause sleepiness?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Allegra (fexofenadine) is less likely to cause sleepiness compared to older antihistamines, with studies showing no sedative properties at recommended doses 1. This is because fexofenadine has limited ability to cross the blood-brain barrier and interact with histamine receptors in the brain. Some key points to consider:

  • Fexofenadine, loratadine, and desloratadine do not cause sedation at recommended doses 1
  • Loratadine and desloratadine may cause sedation at doses exceeding the recommended dose 1
  • Cetirizine and intranasal azelastine may cause sedation at recommended doses 1 If you're concerned about drowsiness while taking an antihistamine, Allegra is generally a good choice, especially when you need to remain alert for activities like driving or working. The standard adult dose is typically 60 mg twice daily or 180 mg once daily. If you do experience unexpected drowsiness with Allegra, consider taking it in the evening or consult your healthcare provider about alternative options. It's also important to note that while most people don't experience significant sedation with Allegra, a small percentage (approximately 1-3%) may still report some drowsiness as a side effect 1.

From the FDA Drug Label

Adverse experiences in subjects aged 12 years and older reported in placebo-controlled seasonal allergic rhinitis clinical trials in the United States Twice- daily dosing with fexofenadine capsulesat rates of greater than 1% Adverse experienceFexofenadine 60 mgTwice Daily(n=679)PlaceboTwice Daily(n=671) ... Drowsiness1.3%0. 9%

Allegra (fexofenadine) can cause sleepiness, as indicated by the reported adverse experience of drowsiness in 1.3% of subjects taking the recommended daily dose of 60 mg twice daily, compared to 0.9% of subjects taking placebo 2.

  • The incidence of drowsiness was similar across subgroups defined by age, gender, and race.
  • Drowsiness was not dose-related.
  • The frequency of drowsiness was slightly higher in subjects taking fexofenadine compared to those taking placebo.

From the Research

Allegra and Sleepiness

  • Allegra, also known as fexofenadine, is a second-generation antihistamine used to treat allergic rhinitis and urticaria.
  • Studies have shown that fexofenadine is non-sedating due to its decreased blood-brain barrier permeability 3, 4.
  • A systematic review and meta-analysis of randomized controlled trials found that fexofenadine produced significantly lower sedative effects compared to first-generation antihistamines and some second-generation antihistamines 5.
  • Another study found that new-generation antihistamines, including fexofenadine, reduced sleep latency and dream anxiety, but did not increase daytime sleepiness 6.
  • A review of the clinical experience with fexofenadine over 25 years found that it has a wide therapeutic window and is not associated with any sedative effects, even at higher than recommended doses 7.

Comparison to Other Antihistamines

  • First-generation antihistamines, such as pheniramine, can cause sedation and impair cognitive function and psychomotor performance 4, 6.
  • Second-generation antihistamines, such as cetirizine and desloratadine, may also cause sedative effects, although to a lesser extent than first-generation antihistamines 4, 5.
  • Fexofenadine has been found to have a favorable safety profile compared to other antihistamines, with fewer sedative effects and less impact on cognitive and psychomotor function 3, 5, 7.

Conclusion is not allowed, so the response will be ended here.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Fexofenadine: review of safety, efficacy and unmet needs in children with allergic rhinitis.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 2021

Research

H1 antihistamines: current status and future directions.

The World Allergy Organization journal, 2008

Research

Assessment of the effects of antihistamine drugs on mood, sleep quality, sleepiness, and dream anxiety.

International journal of psychiatry in clinical practice, 2014

Research

Twenty-five years: The fexofenadine clinical experience.

The World Allergy Organization journal, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.